Praxis Precision Medicines任命全球癫痫领域权威Orrin Devinsky博士担任临床战略负责人

美股速递
Jan 14

精准医疗公司Praxis Precision Medicines, Inc.宣布一项重要人事任命:全球癫痫治疗领域的顶尖专家Orrin Devinsky博士正式加入公司,出任临床战略负责人。这一战略布局彰显了Praxis深耕神经系统疾病治疗领域的决心。

Devinsky博士在癫痫临床研究与治疗方面拥有超过三十年的深厚积淀,其学术成果与临床实践经验在国际上享有盛誉。他的加入将显著强化Praxis在精准神经疗法开发方面的科学领导力,特别是在难治性癫痫创新疗法的临床设计与发展策略上注入关键动能。

此次任命被视为Praxis加速推进其神经科学管线的重要里程碑。公司表示,Devinsky博士的专业洞察将直接应用于核心项目的临床开发路径优化,助力提升临床试验效率与成功率。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10